SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-030392
Filing Date
2021-06-02
Accepted
2021-06-02 07:08:59
Documents
2
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea142051-6k_kamadaltd.htm 6-K 12829
2 PRESS RELEASE DATED JUNE 2, 2021: "KEDRION AND KAMADA ANNOUNCE FDA APPROVAL OF K ea142051ex99-1_kamadaltd.htm EX-99.1 28452
  Complete submission text file 0001213900-21-030392.txt   42257
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 21987661
SIC: 2834 Pharmaceutical Preparations